Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ MF\n@lX
3/rvSR!
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© h/TPd]
oh@r0`J]x
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© g[M@
NuO>zAu
1.Co-stimulators (or co-stimulating molecules) C-Fp)Zs{0
^Js9E
2.NK-kB 8&C
(0H]1
e4)gF*
3.Immunoglobulin superfamily :s'%IGy>:
~v54$#CB
4.antigen-presenting cell (APC) NUnP'X=J,
|(P;2q4>
5.death domain ^p7(
?*s!&-KI
6.CCR and CXCR n#&RY%#`
?@#}%<yEq
7.Lectin (or mitogen) -mkync3
]czy8n$+
8.Clusters of differentiation, CD) *tO<wp&
Q]7Q
9.B7 family 3
#wj-
>ATW/9r
10.Cytotoxic T lymphocyte, CTL) I coL/7k3
~+np7
11.IL-15 and IL-15 receptor (IL-15R) jFXU
xf
I>5@s;
12.MHC restriction `l+SJLyJ%
Ww(_EW
13.Affinity-chromatography E nvs[YZe
Fq9[:
14.Cyctosprin A, CsA "P{&UwMmh
;9PM?Iy[
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) V3o AZ34)
eI}VH BAz
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© cMl%)j-
|u{QI3
#'
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 }SV3PdE
4cQ5E9
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ (OqJet2{+
Vi#im`@
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ _o.Z`]
MQ*#oVqv
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© "AouiZkh
zcKC5vqb
ÃâÒßѧרҵ£º 6EU4
k^pu1g=6I
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ kMl<
:*@|"4
Ïû»¯ÄÚ¿Æ£º @WHd(ka!
%5*#c*)R
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ M@g
gLW
zt2-w/[Q
ѪҺ²¡Ñ§×¨Òµ£º E ZKz-}
|V\.[F2Fe
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿